Particularly, patients carrying the P136L, A54T, c.109+1G>T, or S171R mutations, which had reduced intracellular CTLA4 expression and reduced percentage of transendocytosis compared to HD (Fig. 2d). This evidence concerns the gene CTLA4 and Huntington disease.